CM
IBER

Cohanzick Management’s Ibere Pharmaceuticals IBER Stock Holding History

Cohanzick Management’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-345,252
Closed -$3.48M – 193
2022
Q4 		$3.48M Sell
345,252
-3,100
-0.9% -$31K 1.01% 28
2022
Q3 		$3.45M Buy
+348,352
New +$3.44M 0.84% 36

Cohanzick Management's IBER Position: Q1 2023 in Review

Cohanzick Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 345,252 shares — an estimated $3.48M sold.

Cohanzick Management first reported a position in IBER in Q3 2022 and held it in 2 quarters. The position peaked at $3.48M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

  • Cohanzick Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Cohanzick Management sold 345,252 Ibere Pharmaceuticals shares in Q1 2023, an estimated $3.48M.
  • Cohanzick Management first reported a position in Ibere Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Cohanzick Management's Ibere Pharmaceuticals position peaked at $3.48M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Cohanzick Management's 13F filing for Q1 2023, filed 12 May 2023.